Detalhe da pesquisa
1.
A Common Type 2 Diabetes Risk Variant Potentiates Activity of an Evolutionarily Conserved Islet Stretch Enhancer and Increases C2CD4A and C2CD4B Expression.
Am J Hum Genet
; 102(4): 620-635, 2018 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29625024
2.
PWWP-DOMAIN INTERACTOR OF POLYCOMBS1 Interacts with Polycomb-Group Proteins and Histones and Regulates Arabidopsis Flowering and Development.
Plant Cell
; 30(1): 117-133, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330200
3.
Transamniotic Stem Cell Therapy for Experimental Congenital Diaphragmatic Hernia: Structural, Transcriptional, and Cell Kinetics Analyses in the Nitrofen Model.
Fetal Diagn Ther
; 48(5): 381-391, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33853064
4.
Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes.
Genome Res
; 27(2): 208-222, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27864352
5.
Initial Mechanistic Screening of Transamniotic Stem Cell Therapy in the Rodent Model of Spina Bifida: Host Bone Marrow and Paracrine Activity.
Fetal Diagn Ther
; 47(12): 902-911, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877907
6.
Application of histone modification-specific interaction domains as an alternative to antibodies.
Genome Res
; 24(11): 1842-53, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25301795
7.
Transcriptional Regulation of the Pancreatic Islet: Implications for Islet Function.
Curr Diab Rep
; 15(9): 66, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26272056
8.
Bidirectional Feto-Maternal Traffic of Donor Mesenchymal Stem Cells Following Transamniotic Stem Cell Therapy (TRASCET).
J Pediatr Surg
; 59(2): 290-294, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37945511
9.
Comparative Effects on Fetal Hematopoiesis and Placental Inflammation From Mesenchymal and Hematopoietic Stem Cells as Agents of Transamniotic Stem Cell Therapy (TRASCET) in a Syngeneic Model of Intrauterine Growth Restriction.
J Pediatr Surg
; 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575446
10.
Transamniotic stem cell therapy (TRASCET) for intrauterine growth restriction (IUGR): A comparison between placental and amniotic fluid donor mesenchymal stem cells.
J Pediatr Surg
; 58(2): 305-309, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36372622
11.
Fetal Alloimmune Hemolytic Anemia (AHA) as a Potential Target for Transamniotic Fetal Immunotherapy (TRAFIT).
J Pediatr Surg
; 58(6): 1107-1110, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36914465
12.
Morphometric, Developmental, and Anti-Inflammatory Effects of Transamniotic Stem Cell Therapy (TRASCET) on the Fetal Heart and Lungs in a Model of Intrauterine Growth Restriction.
Stem Cells Dev
; 32(15-16): 484-490, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358376
13.
Early functional analysis on the pulmonary hemodynamic effects of Transamniotic Stem Cell Therapy (TRASCET) in the nitrofen model of congenital diaphragmatic hernia.
J Pediatr Surg
; 58(1): 8-13, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280468
14.
Brain protection by transamniotic stem cell therapy (TRASCET) in a model of intrauterine growth restriction (IUGR).
J Pediatr Surg
; 58(1): 3-7, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344286
15.
Transamniotic Fetal Administration of Genetically Modified Hematopoietic Stem Cells Carrying a Human Transgene in a Syngeneic Rat Model.
Stem Cells Dev
; 32(7-8): 180-184, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719776
16.
Fetal Secretory IgA Delivery via Transamniotic Fetal Immunotherapy (TRAFIT) in a Rodent Model.
J Pediatr Surg
; 58(10): 2050-2053, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029025
17.
Passive perinatal immunotherapy via transamniotic antibody delivery.
J Pediatr Surg
; 57(1): 52-55, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34756583
18.
Routing pathway of syngeneic donor hematopoietic stem cells after simple intra-amniotic delivery.
J Pediatr Surg
; 57(6): 986-990, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279287
19.
Routing kinetics of human immunoglobulin-G after transamniotic fetal immunotherapy (TRAFIT) in a rodent model.
J Pediatr Surg
; 57(6): 1004-1007, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35317944
20.
Intrauterine Growth Restriction (IUGR) as a potential target for transamniotic stem cell therapy.
J Pediatr Surg
; 57(6): 999-1003, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277250